Rawcliffe Adrian
- SEC CIK
- 0001555851
In the past year, 3 open-market sale filings worth $806.6K and no purchases.
Current role at each company
- WVE Wave Life Sciences, Inc.Directoras of Aug 13, 2026
- ADAPY Adaptimmune Therapeutics PLCChief Executive Officeras of Feb 20, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $806.6K
- 3 filings
- Net
- −$806.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rawcliffe Adrian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WVE Wave Life Sciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 12 | 1 day | Rawcliffe AdrianDirector | SSale | −12.7K | $5.29 | −$67.2K | −100.0%0 after | 10b5-1 |
| Dec 10, 2025 (view filing) | Dec 8 | 2 days | Rawcliffe AdrianDirector | SSale | −42.0K | $15.00 | −$630.0K | −76.8%12.7K after | 10b5-1 |
| Nov 14, 2025 (view filing) | Nov 13 | 1 day | Rawcliffe AdrianDirector | SSale | −16.1K | $6.79 | −$109.4K | −55.9%12.7K after | 10b5-1 |
ADAPY Adaptimmune Therapeutics PLC
Chief Executive Officer15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 (view filing) | Jan 17 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −30.6K | $0.58 | −$17.7K | −40.8%44.3K after | |
| Jan 15, 2025 (view filing) | Jan 13-15 | 2 days | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −59.6K | $0.5802 | −$34.6K | −58.9%41.6K after | 3 lots |
| Jan 17, 2024 (view filing) | Jan 16-17 | 1 day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −39.4K | $0.6983 | −$27.5K | −46.8%44.8K after | 2 lots |
| Jan 12, 2024 (view filing) | Jan 11-12 | 1 day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −29.2K | $0.8459 | −$24.7K | −52.5%26.4K after | 2 lots |
| Sep 1, 2023 (view filing) | Sep 1 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −2.40K | $0.78 | −$1.87K | −41.1%3.45K after | |
| Jun 27, 2023 (view filing) | Jun 27 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −2.33K | $0.92 | −$2.15K | −39.9%3.52K after | |
| Jan 17, 2023 (view filing) | Jan 17 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −10.1K | $1.86 | −$18.7K | −43.0%13.4K after | |
| Jan 12, 2023 (view filing) | Jan 11-12 | 1 day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −31.8K | $1.73 | −$54.9K | −56.1%24.9K after | 2 lots |
| Jan 4, 2023 (view filing) | Jan 4 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −5.07K | $1.69 | −$8.57K | −43.3%6.63K after | |
| Sep 1, 2022 (view filing) | Sep 1 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −2.54K | $1.97 | −$5.00K | −43.3%3.32K after |